Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

CiteULike is a free service for managing and discovering scholarly references - click here to get started.

Sign In to gain access to subscriptions and/or personal tools.
Health:
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Hogle, L. F.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Hogle, L. F.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Chemoprevention for Healthy Women: Harbinger of Things to Come?

Linda F. Hogle

Stanford University, USAlhogle{at}leland.stanford.edu

Chemoprevention is a new form of medicalization in which healthy individuals take medications to reduce their risk of getting a disease. For the first time, a cancer chemotherapy agent has been approved for use in women who may be at high risk of getting breast cancer, but do not have the disease. Rather than promoting this remarkable new use of a drug to physicians alone, the manufacturer is advertising it directly to women in print and broadcast media. The article reports a study of women’s responses to these ads and discusses emerging meanings associated with the new category of being ‘at risk.’

Key Words: breast cancer • direct-to-consumer advertising • risk

Health:, Vol. 5, No. 3, 311-333 (2001)
DOI: 10.1177/136345930100500303
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Science Technology Human ValuesHome page
I. Lowy and J. P. Gaudilliere
Localizing the Global: Testing for Hereditary Risks of Breast Cancer
Science Technology Human Values, May 1, 2008; 33(3): 299 - 325.
[Abstract] [PDF]

Home page
 RadiologyHome page
J. Illes, E. Fan, B. A. Koenig, T. A. Raffin, D. Kann, and S. W. Atlas
Self-referred Whole-Body CT Imaging: Current Implications for Health Care Consumers
Radiology, August 1, 2003; 228(2): 346 - 351.
[Abstract] [Full Text] [PDF]